Login / Signup

Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).

Tomono KawaseHiroshi ImamuraRyohei KawabataJin MatsuyamaKazuhiro NishikawaKazuhiro YanagiharaKazuyoshi YamamotoNoriyuki HokiJunji KawadaHisato KawakamiDaisuke SakaiYukinori KurokawaToshio ShimokawaTaroh Satoh
Published in: International journal of clinical oncology (2024)
These findings indicate that S-1 plus docetaxel as first-line treatment for older patients is feasible and that it has promising efficacy against advanced gastric cancer.
Keyphrases
  • locally advanced
  • phase ii study
  • neoadjuvant chemotherapy
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • open label
  • clinical trial
  • lymph node
  • double blind